Luca Richeldi

Summary

Affiliation: University of Modena and Reggio Emilia
Country: Italy

Publications

  1. ncbi An update on the diagnosis of tuberculosis infection
    Luca Richeldi
    Department of Oncology, Hematology, and Respiratory Disease, University of Modena and Reggio Emilia, 41100 Modena, Italy
    Am J Respir Crit Care Med 174:736-42. 2006
  2. ncbi Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents
    Barbara Maria Bergamini
    University of Modena and Reggio Emilia, Department of Respiratory Diseases, Policlinico Hospital of Modena, Via del Pozzo 71, 41100 Modena, Italy
    Pediatrics 123:e419-24. 2009
  3. ncbi T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection
    Luca Richeldi
    Department of Respiratory Disease, University of Modena and Reggio Emilia, Modena, Italy
    Pediatrics 119:e1-5. 2007
  4. ncbi Sarcoidosis: challenging diagnostic aspects of an old disease
    Paolo Spagnolo
    Section of Respiratory Diseases, Department of Oncology, Hematology, and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy
    Am J Med 125:118-25. 2012
  5. ncbi Performance of tests for latent tuberculosis in different groups of immunocompromised patients
    Luca Richeldi
    Section of Respiratory Diseases, Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Italy
    Chest 136:198-204. 2009
  6. ncbi [Role of in vitro tests in the diagnosis of latent tubercular infections]
    Luca Richeldi
    Dipartimento di Oncologia, Ematologia e Patologie dell Apparato Respiratorio, Universita di Modena e Reggio Emilia, Italy
    G Ital Med Lav Ergon 32:269-72. 2010
  7. ncbi Genetic testing in diffuse parenchymal lung disease
    Paolo Spagnolo
    Department of Oncology, Center for Rare Lung Disease, Hematology, and Respiratory Diseases, University of Modena and Reggio Emilia, Via del Pozzo 71, Modena, 41124, Italy
    Orphanet J Rare Dis 7:79. 2012
  8. ncbi Management of idiopathic pulmonary fibrosis
    Stefania Cerri
    Center for Rare Lung Diseases, Department of Oncology, Hematology and Respiratory Diseases, University Hospital Policlinico of Modena, Modena, Italy
    Clin Chest Med 33:85-94. 2012
  9. ncbi Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay
    Luca Richeldi
    Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Policlinico Hospital, Via del Pozzo 71, 41100 Modena, Italy
    Expert Rev Respir Med 2:253-60. 2008
  10. ncbi Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis
    Paola Contini
    Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Modena, Italy
    Multidiscip Respir Med 6:313-7. 2011

Collaborators

  • Giovanni Ferrara
  • Katie Ewer
  • Ajit Lalvani
  • Irene Latorre
  • Andrea Cossarizza
  • Vanni Borghi
  • H Kunst
  • Paolo Spagnolo
  • Stefania Cerri
  • Fabrizio Luppi
  • Paola Contini
  • Barbara Maria Bergamini
  • Monica Losi
  • Alberto Franchi
  • Sarah Gooding
  • Milena Nasi
  • Leonardo Michele Fabbri
  • Pietro Roversi
  • Riccardo Schiavina
  • Francesco Tavalazzi
  • Valerio Di Scioscio
  • Mario Schiavina
  • Andrea Fabiani
  • Fabio Rumpianesi
  • Marisa Meacci
  • Leonardo M Fabbri
  • Fiorella Balli
  • Francesca Vaienti
  • Barbara Meccugni
  • Donatella De Giovanni
  • Roberto D'Amico
  • Kerry Millington
  • Oni Chowdhury
  • Jeremy McNally
  • Ruba Gunatheesan
  • Giovanni Parrinello
  • Tim Hinks
  • Giuliano Franco
  • Cristina Mussini
  • Cristian Bellodi
  • Stefania Maffei
  • Roberto Esposito
  • Enrico Lugli
  • Leonarda Troiano
  • Marcello Pinti

Detail Information

Publications18

  1. ncbi An update on the diagnosis of tuberculosis infection
    Luca Richeldi
    Department of Oncology, Hematology, and Respiratory Disease, University of Modena and Reggio Emilia, 41100 Modena, Italy
    Am J Respir Crit Care Med 174:736-42. 2006
    ....
  2. ncbi Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents
    Barbara Maria Bergamini
    University of Modena and Reggio Emilia, Department of Respiratory Diseases, Policlinico Hospital of Modena, Via del Pozzo 71, 41100 Modena, Italy
    Pediatrics 123:e419-24. 2009
    ..TB (Oxford Immunotec, Abingdon, United Kingdom) show promise of greater accuracy, but they may also be affected by impaired cellular immunity, resulting in indeterminate results (ie, insufficient response in positive-control wells)...
  3. ncbi T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection
    Luca Richeldi
    Department of Respiratory Disease, University of Modena and Reggio Emilia, Modena, Italy
    Pediatrics 119:e1-5. 2007
    ..Our findings demonstrate that this blood test detected latent infection with dormant, yet viable, bacilli and illustrate how enzyme-linked immunospot could improve diagnosis of childhood tuberculosis infection...
  4. ncbi Sarcoidosis: challenging diagnostic aspects of an old disease
    Paolo Spagnolo
    Section of Respiratory Diseases, Department of Oncology, Hematology, and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy
    Am J Med 125:118-25. 2012
    ..In conclusion, we strongly advise that physicians be ready to reconsider the diagnosis of sarcoidosis in the presence of atypical manifestations or persistent/progressive disease despite conventional therapy...
  5. ncbi Performance of tests for latent tuberculosis in different groups of immunocompromised patients
    Luca Richeldi
    Section of Respiratory Diseases, Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Italy
    Chest 136:198-204. 2009
    ....
  6. ncbi [Role of in vitro tests in the diagnosis of latent tubercular infections]
    Luca Richeldi
    Dipartimento di Oncologia, Ematologia e Patologie dell Apparato Respiratorio, Universita di Modena e Reggio Emilia, Italy
    G Ital Med Lav Ergon 32:269-72. 2010
    ..It's therefore desirable that new documents will be produced soon to guide the use of these new tests in clinical routine...
  7. ncbi Genetic testing in diffuse parenchymal lung disease
    Paolo Spagnolo
    Department of Oncology, Center for Rare Lung Disease, Hematology, and Respiratory Diseases, University of Modena and Reggio Emilia, Via del Pozzo 71, Modena, 41124, Italy
    Orphanet J Rare Dis 7:79. 2012
    ..Finally, we discuss practical issues and implications for both patients and physicians of recent advances in the genetics of sarcoidosis and IPF...
  8. ncbi Management of idiopathic pulmonary fibrosis
    Stefania Cerri
    Center for Rare Lung Diseases, Department of Oncology, Hematology and Respiratory Diseases, University Hospital Policlinico of Modena, Modena, Italy
    Clin Chest Med 33:85-94. 2012
    ..Randomized controlled trials represent a valid choice for patients with IPF, and their completion is important in improving both survival and quality of life...
  9. ncbi Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay
    Luca Richeldi
    Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Policlinico Hospital, Via del Pozzo 71, 41100 Modena, Italy
    Expert Rev Respir Med 2:253-60. 2008
    ....
  10. ncbi Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis
    Paola Contini
    Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Modena, Italy
    Multidiscip Respir Med 6:313-7. 2011
    ....
  11. ncbi Room size is the major determinant for tuberculin conversion in health care workers exposed to a multidrug-resistant tuberculosis patient
    Alberto Franchi
    Occupational Health Unit, Policlinico Hospital, 8th Floor, room 8 056, Via Largo del Pozzo 71, 41100 Modena, Italy
    Int Arch Occup Environ Health 80:533-8. 2007
    ..e., index case (IC)]. Aim of the study was to identify the main exposure predictors for the risk of conversion through evaluation of tuberculin screening results...
  12. ncbi Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection
    Giovanni Ferrara
    Section of Respiratory Disease, Department of Oncology, Haematology and Respiratory Disease, University of Modena and Reggio Emilia, Modena, Italy
    Am J Respir Crit Care Med 172:631-5. 2005
    ..As with the TST, immunosuppression may negatively affect the test's performance, with a significant rate of indeterminate results in the most vulnerable population...
  13. ncbi Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study
    Giovanni Ferrara
    Section of Respiratory Disease, Department of Oncology, Haematology, and Respiratory Disease, University of Modena and Reggio Emilia, Via del Pozzo, 71-41100 Modena, Italy
    Lancet 367:1328-34. 2006
    ..Rates of indeterminate and positive results, however, differ between the blood tests, suggesting that they might provide different results in routine clinical practice...
  14. ncbi MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients
    Milena Nasi
    Department of Biomedical Sciences, University of Modena and Reggio Emilia School of Medicine, Via Campi 287, 41100 Modena, Italy
    AIDS 17:1696-8. 2003
    ..The MDR1 C3435Tpolymorphism did not influence response to therapy, suggesting no disadvantages for individuals with a different genotype...
  15. ncbi Interferon gamma assays for tuberculosis
    Ajit Lalvani
    Lancet Infect Dis 5:322-4; author reply 325-7. 2005
  16. ncbi T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure
    Luca Richeldi
    Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, United Kingdom
    Am J Respir Crit Care Med 170:288-95. 2004
    ..tuberculosis after brief exposure. These results help to explain the apparent importance of casual contact for tuberculosis transmission, and may have implications for prevention...
  17. ncbi Early diagnosis of subclinical multidrug-resistant tuberculosis
    Luca Richeldi
    University of Modena and Reggio Emilia and Azienda Ospedaliera Policlinico di Modena, Modena, Italy
    Ann Intern Med 140:709-13. 2004
    ..Large prospective studies that compare benefits and costs of this alternative to tuberculin skin testing are needed...
  18. ncbi Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practice
    Sarah Gooding
    Tuberculosis Immunology Group, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK
    J Infect 54:e169-74. 2007
    ..Rapid determination of tuberculosis infection by ELISpot accelerated the diagnosis of tuberculosis, enabling early treatment initiation...